Portal de Periódicos da CAPES

AUTONOMIC PHARMACOLOGY OF LEUKOTRIENES

1985; Wiley; Volume: 5; Issue: 2 Linguagem: Inglês

10.1111/j.1474-8673.1985.tb00116.x

1365-2680

G Feuerstein,

Biochemical Analysis and Sensing Techniques

Journal of Autonomic PharmacologyVolume 5, Issue 2 p. 149-168 AUTONOMIC PHARMACOLOGY OF LEUKOTRIENES G. FEUERSTEIN, G. FEUERSTEIN Neurobiology Research Division, Department of Neurology, Uniformed Services University of the Health Services, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, U. S. A.Search for more papers by this author G. FEUERSTEIN, G. FEUERSTEIN Neurobiology Research Division, Department of Neurology, Uniformed Services University of the Health Services, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, U. S. A.Search for more papers by this author First published: June 1985 https://doi.org/10.1111/j.1474-8673.1985.tb00116.xCitations: 60AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References AEHRINGHAUS, U., PESKAR, B. A., WITTENBERG, H. R. and WOLBLING, R. H. (1983). Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis. Br. J. Pharmac. 80, 73–80. AHMED, T., GREENBLATT, D. W., BIRCH, S., MARCHETTE, B. and WANNER, A. (1981). Abnormal mucociliary transport in allergic patients with antigen induced bronchospam. Role of slow reacting substances of anaphylaxis. Am. Rev. Respir. Dis. 124, 110–114. AHMED, T. and OLIVER, W. (1983). Does slow-reacting substance of anaphylaxis mediate hypoxic pulmonary vasoconstriction Am. Rev. Respir. Dis. 127, 566–571. AUGSTEIN, J., FARMER, J. B., LEE, T. B., SHEARD, P. and TATTERSALL, M. L. (1973). Selective inhibitor of slow reacting substance of anaphylaxis. Nature, (Lond.), 245, 215–217. AUSTEN, K. F. (1974). Systemic anaphylaxis in the human being. N. Engl. J. Med. 291, 661–664. AUSTEN, K. F., COREY, E. J., DRAZEN, J. M. and LEITCH, A. G. (1983). The effect of indomethacin on the contractile response of the guinea pig lung parenchymal strip to leukotrienes B4, C4, D4, and E4. Br. I. Pharmac. 80, 47–53. BACH, M. K., BRASHLER, J. R., SMITH, H. W., FITZPATRICK, F. A., SUN, F. F. and McGUIRE, J. C. (1982). 6, 9-deepoxy-6, 9-N-(phenylimino)- A −6, 8-prostaglandin I, (U-60,257); a new inhibitor of leukotriene C and D synthesis: in vitro studies. Prostaglandins, 23, 759–769. BACH, M. K. and BRASHLER, J. R. (1974). In vivo and in-vitro production of slow reacting substance in the rat upon treatment with calcium ionophores. J. Immunol. 113, 2040–2044. BADR, K. F., BAYLIS, C., PFEFFER, J. M., PFEFFER, M. A., SOBERMAN, R. J., LEWIS, R. A., AUSTEN, K. F., COREY, E. J. and BRENNER, B. M. (1984). Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Circ. Res. 54, 492–499. BAYORH, M. B., ZUKOWSKA-GROJEC, S., KOPIN, I. J. and FEUERSTEIN, G. (1984). Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation angiotensin and vasopressin in the pithed spontaneously hypertensive rats. J. Pharmac. exp. Ther. 231, 85–90. BAYORH, M. A., FADEN, A. I. and FEUERSTEIN, G. (1985). Differential hemodynamic effects of leukotriene D4 in anethetized rats: Evaluation by directional pulsed Doppler technique. Prostag. Leukot. Medicine, 17, 229–241. BAZAN, N. G. (1970). Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biphys. Acta. 218, 1–10. BHAKOO, K. K., LASCELLES, P. T., CROCKARD, H. A. and AVERY, S. F. (1982). Brain prostaglandins and cerebral edema following temporary vascular occlusion in gerbils (Abst.). Proc. Int. Conf. on Prostaglandins, p. 796. BISGAARD, H., FORD-HUTCHINSON, A. W., CHARLESON, S. and TAUDORF, E. (1984). Detection AUTONOMIC PHARMACOLOGY OF LEUKOTRIENES 163 of leukotriene C4 like immunoreactivity in tear fluid from subjects challenged with specific allergen. Prostaglandins, 27, 369–374. BISGAARD, H., KRISTENSEN, J. and SONDERGAARD, (1982). The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins, 23, 797801. BJORK, J., DAHLEN, S. E., HEDQVIST, P. and ARFORS, E. (1983). Leukotrienes B4 and C4 have distinct microcirculatory actions in vivo. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 1–6. BJORK, J., HEDQVIST, P. and ARFORS, K. E. (1982). Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation, 6, 189–200. BLACK, K. L. (1984). Leukotriene C4 induces vasogenic cerebral edema in rats. Prostaglandins Leukotrienes Med. 14, 339–340. BONGRANI, S., FOLCO, G. C., RAZZETTI, R. and SCHIANTARELLI, P. (1983). β-adrenoceptor blockade is the basis of guinea-pig bronchial hyper-responsiveness to leukotriene C4 and other agonists. Br. J. Pharmac. 79, 839–848. BORGEAT, P. and SAMUELSSON, B. (1979a). Metabolism of arachidonic acid in polymorphonuclear leukocytes: structure analysis of novel hydroxylated compounds. J. Biol. Chem. 254, 7865–7869. BOSTERLING, B. and TRUDELL, J. R. (1984). Production of 5-and 15-hydroperoxyeicosatetraenoic acid from arachidonic acid by halothane-free radicals generated by UV-irradiation. Anesthesiology, 60, 209–213. BOYD, L. M., EZRA, D., FEUERSTEIN, G. and GOLDSTEIN, R. E. (1983). Effects of FPL 55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart. Eur. J. Phamac. 89, 307–311. BRAY, M. A., CUNNINGHAM, F. M., FORDHUTCHINSON, A. W. and SMITH, M. J. H. (1981). Leukotriene B4: A mediator of vascular permeability. Br. J. Pharmac. 72, 483–486. BRIGHAM, K., BOWERS, R. E. and McKEEN, C. R. (1981). Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J. Clin. Invest. 67, 1103–1110. BROCKLEHURST, W. E. (1960). The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J. Physiol. (Lond.), 151, 416435. BROCKLEHURST, W. E. (1962). Slow reacting substance and related compounds. Prog. Allergy, 6, 539–558. BRUNE, K., AEHRINGHAUS, U. and PESKAR, B. A. (1984). Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages. Agentsand Actions, 14, 729–734. BULT, H. and HERMAN, A. G. (1982). Prostaglandins and circulatory shock. In Cardiovascular Pharmacology of the Prostaglandins, ed. A. G. Herman P. M. VanHoutte, H. Benolin, A. Goossens Raven Press, New York , pp 327–345. BURKA, J. F. and SAAD, M. H. (1984). Mediators of arachidonic acid-induced contractions of indomethacintreated guinea-pig airways: leukotrienes C4 and D4. Br. J. Pharmac. 81, 465–473. BURKE, J. A. and LEVI, R. (1980). Slow-reacting substance of anaphylaxis (SRS-A): direct and indirect cardiac effects. Fed. Proc. (Abstr.), 39, 389. BURKE, J. A., LEVI, R. and GLEASON, J. G. (1984). Antagonism of the cardiac effects of leukotriene C4 by compound SKF 88046: dissociation of effects on contractility and coronary flow. J. Cardiovasc. Pharmac. 6, 122–125. BURKE, J. A., LEVI, R., GUO, Z. G. and COREY, E. J. (1981). Leukotrienes C4, D4 and E4: Effects' on human and guinea-pig cardiac preparations in vitro. J. Pharmac. exp. Ther. 221, 235–241. CAMP, R. D. R., COUTTS, A. A., GREAVES, M. W., KAY, A. B. and WALPORT, M. J. (1983). Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br. J. Pharmac. 80, 497–502. CAPURRO, N. and LEVI, R. (1975). The heart as a target organ in systemic allergic reactions: comparison of cardiac anaphylaxis in vivo and in vitro. Circ. Res. 36, 520–528. CARRAHER, R., HAHN, D. W., RITCHIE, D. M. and McGUIRE, J. L. (1983). Involvement of lipoxygenase products in myometrial contractions. Prostaglandins, 26, 23–32. CASEY, F. B., APPLEBY, B. J. and BUCK, D. C. (1983). Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist FPL 55712. Prostaglandins, 25, 1–11. CASEY, L., CLARKE, J., FLETCHER, J. and RAMWELL, P. (1982). Cardiovascular, respiratory and hematolic effects of leukotriene D4 in primates. Adv. Prostaglandin Thromboxane Leukotriene Res. 9, 201–210. CHANG, W. C., FUKUDA, S. and TAI, H. H. (1983). Cigarette smoking stimulates lipoxygenase but not cyclooxygenase pathway in platelets. Biochem. Biophys. Res. Commun. 115, 499–505. CHAPNICK, B. M. (1984). Divergent influences of leukotrienes C4, D4 and E4 on mesenteric and renal blood flow. Am. J. Physiol. 246, H518–H524. CHASIN, M. and SCOTT, C. (1978). Inhibition of cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist. Biochem. Pharmac. 27, 2065–2067. CHENG, J. B. and TOWNLEY, R. G. (1984). Identification of leukotriene D4 receptor binding sites in guinea-pig lung homogenates using 3H-leukotriene D4. Biochem. Biophys. Res. Commun. 118, 20–26. COCEANI, F., JHAMANDAS, V. M., BODACH, E., LABUC, J., OLLEY, P. M. and BORGEAT, P. (1982). Evidence against a role for lipoxygenase-derived products of arachidonic acid in the lamb ductus arteriosus. Can. J. Physiol. Pharmac. 60, 345–349. COLES, S. J., NEILL, K. H., REID, L. M., AUSTEN, K. F., NIL, Y., COREY, E. J. and LEWIS, R. A. (1983). Effects of leukotrienes C4 and D4 on glycoprotein and lysozome secretion by human bronchial mucosa. Prostaglandins, 25, 155–170. DAHLEN, S. E., BJORK, J., HEDQVIST, P., ARFORS, K. E., HAMMARSTROM, D. LINDGREN, J. A. and SAMUELSON, B. (1981). Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. 78, 3887–3891. DAHLEN, S. E., HANSSON, G., HEDQVIST, P., BJORK, T., GRANSTROM, E. and DAHLEN, B. (1983). Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4. Proc. Natl. Acad. Sci. 80, 1712–1716. DELAGE, C. and IREY, N. S. (1972). Anaphylactic deaths: a clineopathologic study of 43 cases. J. Forensic Sci. 17, 525–540. DEMBINSKA-KIEC, A., SIMMET, T. and PESKAR, B. A. (1984a). Formation of leukotriene C4-like material by rat brain tissue. Eur. J. Pharmac. 99, 57–62. DEMBINSKA-KIEC, A., SIMMET, T. and PESKAR, B. A. (1984b). Release and vasoconstrictor effect of leukotriene C4-like immunoreactive material in the anaphylactic guinea-pig mesenteric vascular bed. Eur. J. Pharmac. 101, 259–262. DENIS, D., CHARLESON, S., RACKHAM, A., JONES, T. R., FORD-HUTCHINSON, A. W., LORD, A., CIRINO, M., GIRARD, Y., LARUE, M. and ROKACH, J. (1982). Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone. Prostaglandins, 24, 801–814. DiNICOLA, A. F. (1983). Might hyperthyroxinemic states exacerbate bronchial asthma by stimulating the production of leukotriene C4, D4 or E4 Med Hypotheses, 10, 199–206. DRAZEN, J. M., AUSTEN, K. F., LEWIS, R. A., CLARK, D. A., GOTO, G., MARFAT, A. and COREY, E. J. (1980). Comparative airway and vascular activities of leukotrienes C1 and D in vivo and in vitro. Proc. Natl. Acad. Sci. 77, 4354–4354. ELLIS, E. F. (1979). Allergic disorders. In 'Nelson Textbook of Pediatrics', 11th Ed., Eds V. C. Vaughan, E. J. McKay, R. E. Behrman W. B. Saunders Co., London , p. 630. ENJETI, S., BLEECKER, E. R., SMITH, P. L., RABSON, J., PERMUTT, S. and TRAYSTMAN, R. J. (1983). Hemodynamic mechanisms in anaphylaxis. Circ. Shock, 11, 297–309. EZEAMUZIE, I. C. and ASSEM, E. S. K. (1983). Effects of leukotrienes C4 and D4 on guinea-pig heart and the participation of SRS-A in the manifestations of guinea-pig cardiac anaphylaxis. Agent Actions, 13, 182–187. EZRA, D., BOYD, L. M., FEUERSTEIN, G. and GOLDSTEIN, R. E. (1983). Coronary constriction by leukotriene C4, D4 and E4 in the intact pig heart. Am. J. Cardiol. 51, 1451–1454. EZRA, D., FEUERSTEIN, G., ERNE, J. and GOLDSTEIN, R. E. (1984). Biphasic coronary flow response to sustained leukotriene D4 administration. Proc. Am. Coll. Cardiol., (Abstr.), 33rd Ann. Conf., Dallas , Texas . FATH, J. J. and CERRA, F. B. (1984). The therapy of anaphylactic shock. Drug Intell. Clin. Pharm. 18, 14–21. FEIGEN, G. A. and PRAGER, D. J. (1969). Experimental cardiac anaphylaxis. Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart. Am. J. Cardiol. 24, 474–491. FEIGEN, L. P. (1983). Differential effects of leukotrienes C4, D4 and E4 in the canine, renal and mesenteric vascular beds. J. Pharmac. exp. Ther. 225, 682–687. FENIUK, L. and KENNEDY, I. and WHELAN, C. J. (1982a). The contractile action of slow reacting substance of anaphylaxis (SRS-A) on rat isolated fundic strip and guinea-pig isolated ileum and its antagonism by FPL 55712.3. Pharm. Pharmac. 34, 586–588. FENIUK, L., KENNEDY, I. and WHELAN, C. J. (1982b). Cardiovascular actions of leukotriene C4, D4 and E4 in the anesthetized cat. In ' Leukotrienes and other lipoxygenase products', Ed P. J. Piper John Wiley and Sons, Ltd., Chichester . pp. 108–112. FEUERSTEIN, G. (1984). Leukotrienes and the cardiovascular system. Prostaglandins, 27, 781–802. FEUERSTEIN, G., ZUKOWSKA-GROJEC, Z. and KOPIN, I. J. (1981). Cardiovascular effects of leukotriene D4 in SHR and WKY rats. Eur. J. Pharmac. 76, 107–110. FINDLAY, S. R., LEARY, T. M., PARKER, C. W., BLOOMQUIST, E. I. and SCHEID, C. R. (1982). Contractile events induced by LTD4 and histamine in smooth muscle - a function of Ca2+ utilization. Am. J. Physiol. 243, C133–C139. FINDLAY, S. R., LICHTENSTEIN, L. M., SIEGEL, H. and TRIGGLE, D. J. (1981). Mechanisms of contraction induced by partially purified slow reacting substance from human polymorphonuclear leukocytes and leukotriene D in guinea pig ileal smooth muscle. J. Immunol. 126, 17281730. FLECKENSTEIN, A. (1977). Specific Pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmac. Toxicol. 17, 149–166. FLEISCH, J. H., RINKEMA, L. E. and BAKER, S. R. (1982). Evidence for multiple leukotriene D4 receptors in smooth muscle. Life Sci. 31, 577–581. FORSTERMANN, U. and NEUFANG, B. (1984). C-6Sulfidopeptide leukotrienes are unlikely to be involved in the endothelium dependent relaxation of rabbit aorta by acetylcholine. Prostaglandins, 27, 181–191. GAUDET, R. J., ALAM, I. and LEVINE, L. (1980). Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J. Neurochem. 35, 653–658. GLEASON, J. G., KRELL, R. D., WEICHMAN, B. M., ALI, F. E. and BERKOWITZ, B. (1982). Comparative pharmacology and antagonism of synthetic leukotrienes on airway and vascular smooth muscle. Adv. Prostaglandin Thromboxane Leukotriene Res. 9, 243–250. GOLDENBERG, M. M. SUBERS, E. M. (1982). The reactivity of rat isolated gastrointestinal tissues to leukotrienes. Eur. J. Pharmac. 78, 463–46. HAAS, F., and BERGOFSKY, E. H. (1972). Role of mast cell in the pulmonary pressor response to hypoxia. J. Clin. Invest. 51, 3154–3162. HAMBERG, M. and SAMUELSSON, B. (1974). Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. 71, 3400–3404. HAMMARSTROM, S., MURPHY, R. C., SAMUELSSON, B., CLARK, D. A., MIOSKOWSKI, C., and COREY, E. J. (1979). Structure of leukotriene C: identification of the amino acid part. Biochem. Biophys. Res. Commun. 91, 1266–1272. HAND, J. M., WILL, J. A. and BUCKNER, C. K. (1983). Enhancement by histamine of the contractile effects of leukotriene D4 on extralobar pulmonary arteries isolated from the guinea-pig. Eur. J. Pharmac. 87, 341–343. HAND, J. M., WILL, J. A. and BUCKNER, C. K. (1981). Effects of leukotrienes on isolated guinea-pig pulmonary arteries. Eur. J. Pharmac. 76, 439–442. HANNA, C. J., BACH, M. K., PARE, P. D. and SCHELLENBERG, R. R. (1981). Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature (Lond.), 290, 343–344. HEDMAN, S. E. and ANDERSON, R. G. G. (1982). Effects of SRS (slow reacting substance) on cyclic nucleotides in guinea pig tracheal muscle. Acta. Pharmac. Toxicol. 50, 30–34. HEDQVIST, P., DAHLEN, S. E. and BJORK, J. (1982). Pulmonary and vascular actions of leukotrienes. Adv Prostaglandin Thromboxane Leukotriene Res. 9, 187–200. HEDQVIST, P., DAHLEN, S. E., GUSTAFSSON, L., HAMMARSTROM, S. and SAMUELSSON, B. (1980). Biological profile of leukotrienes C4 and D4. Acta. Physiol. Scand. 110, 331–333. HOGABOOM, G. K., MONG, S., WU, H. L. and CROOKE, S. T. (1983). Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. Biochem. Biophys. Res. Commun. 116, 1136–1143. HOLME, G., BRUNET, G., PIECHUTA, H., MASSON, P., GIRARD, Y. and ROKACH, J. (1980). The activity of synthetic leukotriene C-1 on guinea-pig trachea and ileum. Prostaglandins, 20, 717–728. HUGHES, J. M., SEALE, J. P. and TEMPLE, D. M. (1983). Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in-vitro: Selective antagonism by f3-adrenoceptor antagonists. Eur. J. Pharmac. 95, 239–245. JACOBS, E. R. and BONE, R. C. (1983). Mediators of septic lung injury. Med. Clin. North Am. 67, 701–715. JONES, T., MASSON, P., HAMEL, R., BRUNET, G., HOLME, G., GIRARD, Y., LARUE, M. and ROKACH, J. (1982). Biological activity of leukotriene sulfones on respiratory tissues. Prostaglandins, 24, 279–291. JONES, T. R., DAVIS, C. and DANIEL, E. E. (1982). Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle. Can. J. Physiol. Pharmac. 60, 638–643. KARAS, J. S. and STANBURY, J. B. (1965). Fatal radiation syndrome from an accidental nuclear excursion. New Engl. J. Med. 272, 755–761. KAY, A. B. (1983). Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Eur. J. Respir. Dis. (Suppl. 129), 64, 1–44. KELLAWAY, C. H. and TRETHEWIE, E. R. (1940). The liberation of a slow reacting smooth muscle stimulating substance in anaphylaxis. Q. J. Exp. Physiol. 3G, 121141. KENDALL, R. A. and TARGAN, S. (1980). The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolitic process: effector activation and NK cell-target cell conjugate lytic inhibition. J. Immunol. 125, 27702777. KIRCHNER, T. and WEICHMAN, B. M. (1984). Propranolol potentiates leukotriene D4-induced bronchoconstriction and enhances antagonism by FPL 55712. Prostaglandins, 27, 119–129. KITO, G., OKUDA, H., OHKAWA, S., TERAO, S. and KIKUCHI, K. (1981). Contractile activities of C4 leukotrienes and D4 on vascular strips from rabbits. Life Sci. 29, 1325–1332. KOREN, H. S., ANDERSON, S. J., FISCHER, D. G., COPELAND, C. S. and JENSEN, P. J. (1981). Regulation of human natural killing. I. The role of monocytes, interferon and prostaglandins. J. Immunol. 127, 20072013. KOSHIHARA, Y., NEICHI, T., MUROTA, S. I., LAO, A. N., FUJIMOTO, Y. and TATSUNO, T. (1984). Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim. Biophys. Acta. 792, 92–97. KRELL, R. D., TSAI, B. S., BERDOULAY, A., BARONE, M. and GILES, R. E. (1983). Heterogeneity of leukotriene receptors in guinea-pig trachea. Prostaglandins, 25, 171–178. KRILIS, S., LEWIS, R. A., COREY, E. J. and AUSTEN, K. F. (1983). Specific receptors for leukotriene C4 on a smooth muscle cell line. J. Clin. Invest. 72, 1516–1519. KUHN, H., PONICKE, K., HALLE, W., SCHEWE, T. and FORSTER, W. (1983). Evidence for the presence of lipoxygenase pathway in cultured endothelial cells. Biomed. Biochim. Acta. 42, K1–K4. LETTS, L. G., NEWMAN, D. L., GREENWALD, S. E. and PIPER, P. J. (1983). Effects of intra-coronary administration of leukotriene D4 in the anesthetized dog. Prostaglandins, 26, 563–572. LETTS, L. G. and PIPER, P. J. (1982). The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br. J. Pharmac. 76, 169–176. LETTS, L. G. and PIPER, P. J. (1983). Cardiac actions of leukotrienes B4, C4, D4 and E4 in guinea-pig and rat in vitro. Adv. Prostaglandin Thromboxane Leukotriene Res. 11, 391–395. LETTS, L. G., PIPER, P. J. and NEWMAN, D. L. (1982). Leukotrienes and their action in the coronary circulation. In ' Leukotrienes and other lipoxygenase products'. Ed P. J. Piper John Wiley and Sons, Ltd., Chichester , pp 94107. LEVI, R. and BURKE, J. A. (1980). Cardiac anaphylaxis: SRS-A potentiates and extends the effects of released histamine. Eur. J. Pharmac. 62, 41–49. LEVINE, L. (1983). Inhibition of the A-23187-stimulated leukotriene and prostaglandin biosynthesis of rat basophil leukemia (RBL-1) cells by non-steroidal anti-inflammatory drugs, antioxidants and calcium channel blockers. Biochem. Pharmac. 32, 3023–3026. LEWIS, R. A., DRAZEN, J. M., AUSTEN, K. F., TODD, M., BRION, F., MARFAT, A. and COREY, E. J. (1981). Contractile activities of structural analogs of leukotrienes C and D: role of the polar substituents. Proc. Natl. Acad. Sci. 78, 4579–4583. LUX, W. E., Jr., FEUERSTEIN, G. and FADEN, A. I. (1983a). Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs. Prostaglandins Leukotrienes Med. 10, 301–307. LUX, W. E., Jr., FEUERSTEIN, G. and FADEN, A. I. (1983b). Alteration of leukotriene D4 hypotension by thyrotropin-releasing hormone. Nature (Lond.), 320, 822824. LUX, W. E. Jr., FEUERSTEIN, G. and FADEN, A. I. (1983c). Thyrotropin releasing hormone reverses experimental anaphylactic shock through non-endorphin related mechanisms. Eur. J. Pharmac. 90, 301–302. LUX, W. E., Jr., FEUERSTEIN, G., SMITH, G. P. and FADEN, A. I. (1982). Effects of pharmacologic interventions of leukotriene D4 hypotension in unanesthetized guinea pig. In ' Leukotrienes and other lipoxygenase products. ed. P. J. Piper John Wiley and Sons, Ltd., Chichester . pp. 338–342. MACLOUF, J., FRUTEAU, DE LACLOS B. and BORGEAT, P. (1982). Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid. Proc. Natl. Acad. Sci. 79, 6042–6046. MAROM, Z., SHELHAMER, J. H., BACH, M. K., MORTON, D. R. and KALINER, M. (1982). Slow reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am. Rev. Respir. Dis. 126, 449–451. McLEOD, L. J., PIPER, P. J. and STANTON, A. W. B. (1984). Leukotriene C4 and D4 are potent constrictors of the porcine renal vascular bed. Br. J. Pharmac. 81, Proceedings Supplement, 65P. METZ, S. A., MURPHY, R. C. and FUJIMOTO, W. (1984). Effects on glucose-induced insulin secretion of lipoxygense-derived metabolites of arachidonic acid. Diabetes, 33, 119–124. METZ, S. A., FUJIMOTO, W. and ROBERTSON, R. P. (1983). Lipoxygenation of arachidonic acid: a pivotal step in stimulus secretion coupling in the pancreatic beta cell. Endocrinology, 111, 2141–2143. METZ, S. A., VAN ROLLINS, M., STRIFE, R., FUJIMOTO, W. and ROBERTSON, R. P. (1983). Lipoxygenase pathway in islet endocrine cells: oxidative metabolism of arachidonic acid promotes insulin release. J. Clin. Invest. 71, 1191–1205. MICHELASSI, F., LANDA, L., HILL, R. D., LOWENSTEIN, E., WATKINS, W. D., PETKAU, A. J. and ZAPOL, W. M. (1982). Leukotriene D4: A potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science, 217, 841–843. MONG, S., WU, H. L., HOGABOOM, G. K., CLARK, M. and CROOKE, S. T. (1984). Characterization of the leukotriene D4 receptor in guinea-pig lung. Eur. J. Pharmac. 102, 1–11. MONG, S., HOGABOOM, G. K., WU, H. L., CLARK, M. and CROOKE, S. T. (1983). Characterization of leukotriene receptor ligand binding. Pharmacologist, 25, 201–209. MORELY, J., PAGE, C. and PAUL, W. (1981). Leukotrienes, SRS-A and the vascular manifestations of PCA. Agents Actions, 11, 585–587. MOSKOWITZ, M. A., KIWAK, K. J., HEKIMIAN, K. and LEVINE, L. (1984). Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science. 224, 886–888. MUCCITELLI, R. M., OSBORN, R. R. and WEICHMAN, B. M. (1983). Effect of inhibition of thromboxane production on the leukotriene D4-mediated bronchocontriction in the guinea-pig. Prostaglandins, 26, 197–206. NAKAO, J., ITO, H., OOYAMA, T., CHANG, W. C. and MUROTA, S. (1983). Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5, 8, 10, 14-eicosatetraenoic acid. Effects of A23187, nicardipine and trifluoperazine. Atherosclerosis, 46(3), 309–319. NICOSIA, S., CROWLEY, H. J., OLIVA, D. and WELTON, A. F. (1984). Binding sites for 3H-LTC4 in membranes from guinea pig deal longitudinal muscle. Prostaglandins, 27, 483–494. NUGTEREN, D. H. (1975). Arachidonate lipoxygenase in blood platelets. Biochim. Biophys. Acta. 380, 299–307. OGLETREE, M. and BRIGHAM, K. (1982). Effects of cyclooxygenase inhibitors on pulmonary vascular responses to endotoxin in unanesthetized sheep. Prostaglandins Leukotrienes Med. 8, 489–502. OGLETREE, M. L., BRIGHAM, K. L. OATES, K. L. and HUBBARD, W. C. (1981). Increased flux of 5-HETE in sheep lung lymph during pulmonary leukostasis after endotoxin. Fed. Proc. (Abst), 40, 767. O'ROURKE, S. T. and RUDY, T. A. (1984). Intracerebroventricular and preoptic injections of leukotrienes C4, D4 and E4 in the rat: lack of febrile effect. Brain Res. 295, 283–288. PALMER, M. R., MATHEWS, W. R., HOFFER, B. J. and MURPHY, R. C. (1981). Electrophysiological response of cerebellar purkinje neurons to leukotriene D4 and 134. J. Pharmac. exp. Ther. 219, 91–96. PATEL, K. R. (1981). Calcium antagonists in exercise induced asthma. Br. Med, J. 282, 932–933. PATERSON, N. A. M., BURKA, J. F. and CRAIG, I. D. (1981). Release of slow reacting substance of anaphylaxis from dispersed pig lung cells: effect of cyclooxygenase and lipoxygenase inhibitors. J. Allergy Clin. Immunol. 67, 426–434. PAZENBACK, M. J. and KALEY, G. (1983). Leukotriene D4 reduces coronary blood flow in the anesthetized dog. Prostaglandins, 25, 661–670. PEATFIELD, A. C., PIPER, P. J. and RICHARDSON, P. S. (1982). The effect of leukotriene C4 on mucin output in the cat trachea. J. Physiol. (Lond.), 325, 56P–57P. PECK, M. J., PIPER, P. J. and WILLIAMS, T. J. (1981). The effect of leukotrienes C4 and D4 on the microvasculature of the guinea-pig skin. Prostaglandins, 21, 315–321. PFEFFER, M. A., PFEFFER, J. M., LEWIS, R. A., BRAUNWALD, E., COREY, E. J. and AUSTEN, K. F. (1983). Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. Am. J. Physiol. 244, H628–H633. PIPER, P. J., LETTS, L. G., TIPPINS, J. R. and BARNETT, K. (1983). Generation of a substance with the biological properties of a leukotriene from porcine vascular tissue. In ' Leukotrienes and other lipoxygenase products. ed. P. J. Piper John Wiley and Sons, Ltd., Chichester . pp. 299–306. PIPER, P. J. and SAMHOUN, M. N. (1983). Comparison of the actions of leukotriene E4 with those of leukotriene B4, C4 and D4 on guinea-pig lung and ileal smooth muscle in vitro. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 127–131. PIPER, P. J. (1982). Pharmacology and Biochemistry of leukotrienes. Eur., Respir. Dis., (Suppl) 63, 122, 54–61. PIPER, P. J. and SAMHOUN, M. N. (1981). The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of the guinea pig, rabbit and rat. Prostaglandins, 21, 793–803. PIPER, P. J., TIPPINS, J. R., MORRIS, H. R. and TAYLOR, G. W. (1979). Arachidonic acid metabolism and SRS-A. In ' Arachidonic acid metabolism in inflammation and thrombosis'. Ed K. Brune and M. Baggidini, Basel/Birkhauser , pp. 37–48. PONG, S. S., DEHAVEN, R. N., KUEHL, F. A. and EGAN, R. W. (1983). Leukotriene C4 binding to rat lung membranes. J. Biol. Chem. 258, 9616–9619. RITCHIE, D. M., HAHN, D. W. and McGUIRE, J. L. (1984). Smooth muscle contraction as a model to study the mediator role of endogenous lipoxygenase products of arachidonic acid. Life Sci. 34, 509–513. ROSENTHAL, A. and PACE-ASCIACK, C. R. (1983). Potent vasoconstriction of the isolated perfused rat kidney by leukotrienes C4 and D4. Can. J. Physiol. Pharmac. 61, 325–328. ROTH, D. M., REIBEL, D. K. and LEFER, A. M. (1984). Altered coronary vascular responsiveness to leukotrienes in alloxan-diabetic rats. Circ. Res. 54, 388–395. ROTH, D. M. and LEFER, A. M. (1983). Studies on the mechanism of leukotriene induced coronary artery constriction. Prostaglandins, 26, 573–581. SAMEULSSON, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568–575. SAMUELSSON, B. and HAMMARSTROM, S. (1980). Nomenclature for leukotrienes. Prostaglandins, 19, 645648. SAMUELSSON, B., BORGEAT, P., HAMMARSTROM, S. and MURPHY, R. C. (1979). Introduction of a nomenclature: leukotrienes. Prostaglandins, 17, 785–787. SASAKI, T., WAKAI, S., ASANO, T., WATANABE, T., KIRINO, T. and SANO, K. (1981). The effect of lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J. Neurosurg. 54, 357–365. SCHIANTARELLI, P., BONGRANI, S. and FOLCO, G. (1981). Bronchospasm and pressor effects induced in the guinea-pig by leukotriene C4 are probably due to release of cyclooxygenase products. Eur. J. Pharmac. 73, 363–366. SEAMAN, W. E. (1983). Human natural killer cell activity is reversibly inhibited by antagonists of lipoxygenation. J. Immunol. 131, 2953–2957. SHELHAMER, J. H., MAROM, Z., SUN, F., BACH, M. K. and KALINER, M. (1982). The effects of arachinoids and leukotrienes on the release of mucus from human airways. Chest, 81, 36S–37S. SIROIS, P., KEROUAC, R., ROY, S., BORGEAT, P., PICARD, S. and RIOUX, F. (1981). In vivo effects of leukotriene B4, C4 and D4: Evidence that changes in blood pressure are mediated by prostaglandins. Prostaglandins Leukotrienes Med. 7, 363–373. SMEDEGARD, G., HEDQVIST, P., DAHLEN, S. E., REVENAS, B., HAMMARSTROM, S. and SAMUELSSON, B. (1982). Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey. Nature (Lond.), 295, 327–329. SMITH, H. W., BACH, M. K., HARRISON, A. W., JOHNSON, H. G., MAJOR, N. J. and WASSERMAN, M. A. (1982). The synthesis of 6, 9-deepoxy-6, 9-NPhenolimino-Δ6,8-prostaglandin I, a novel inhibitor of leukotriene C and D synthesis. Prostaglandins, 24, 543546. SMITH, R. J., SUN, F. F., BOWMAN, B. J., IDEN, S. S., SMITH, H. W. and McGUIRE, J. C. (1982). Effect of 6, 9deepoxy-6, 9-(phenylimino)Δ-6, 8-prostaglandin I1 (U60, 257) an inhibitor of leukotriene synthesis, on human neutrophil function. Biochem. Biophys. Res. Commun. 109, 943–949. SMITH, P. L., KAGEY-SOBOTKA, A., BLEECKER, E. R., TRAYSTMAN, R., KAPLAN, A. P., GRALNIK, H., VALENTINE, M. D., PERMUTT, S. and LICHTENSTEIN, L. M. (1980). Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 66, 1072–1080. SOK, D. E., HAN, C. Q., PAI, J. K. and SIH, C. J. (1982). Inhibition of leukotriene biosynthesis by acetylenic analogs. Biochem. Biophys. Res. Commun. 107, 101–108. SOTER, N. A., LEWIS, R. A., COREY, E. J. and AUSTEN, K. F. (1983). Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, LTB4) in human skin. J. Invest. Dermatol. 80, 115–119. STJERNSCHANTZ, J. and SHERK, T. (1982). Effect of leukotrienes in the eye. Acta. Physiol. Scand. 508, (Suppl) (Abs) 38. STJERNSCHANTZ, J., SHERK, T. and SEARS, M. (1984). Ocular responses to leukotriene C4 and D4 in the cat. Prostaglandins, 27, 5–15. SUN, F. F. and McGURE, J. C. (1983). Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6, 9-deepoxy-6, 9-N-(phenylimino)-Δ-6, 8-prostaglandin I1. Prostaglandins, 26, 211–221. SUZUKI, N., NAKAMURA, T., IMABAYASHI, S., ISHIKAWA, Y., SASAKI, T. and ASANO, T. (1983). Identification of 5-hydroxy eicosatetraenoic acid in cerebrospinal fluid after subarachnoid hemorrhage. J. Neurochem. 41, 1186–1189. TAGARI, P., BOULLIN, D. J., DU-BOULAY, G. H. and AITKEN, V. (1983a). Vasoconstrictor and vasodilator effects of LTD4 and FPL 55712 on human and rat cerebral arteries. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 357–364. TAGARI, P., DU BOULAY, G. H., AITKEN, V. and BOULLIN, D. J. (1983b). Leukotriene D4 and the cerebral vasculature in vivo and in vitro. Prostaglandins Leukotriene Med. 11, (3), 281–297. TERASHITA, Z. I., FUKUI, H., HIRATA, M., TERAO, S., OHKAWA, S., NISHIKAWA, K. and KIKUCHI, S. (1981). Coronary vascoconstriction and PGI2 release by leukotrienes in isolated guinea pig hearts. Eur. J. Pharmac. 73, 357–361. UENO, A., TANAKA, K., HIROSE, R., SHISHIDO, M. and KATORI, M. (1983). Possible involvement of thromboxane in hypertensive and bronchoconstrictive effects of leukotrienes C4 and D4. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 139–144. UENO, A., TANAKA, K., KATORI, M., HAYASHI, M. and ARAI, Y. (1981). Species differences in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins, 21, 637–648. VARGAFTIG, B. B., LEFORT, J. and MURPHY, R. C. (1981). Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig. Eur. J. Pharmac. 72, 417–418. VINCENT, J. E., WALLENBERG, H. C. S. and ZIJLSTRA, F. J. (1983). Effect of prostaglandin F2α, prostacyclin and leukotriene C4 on the contractile activity of human uterine arteries. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 417–422. WALSH, M. F. and PEK, S. B. (1984). Effects of lipoxygenase and cyclooxygenase inhibitors on glucose stimulated insulin secretion from the isolated perfused rat pancreas. Life Sci. 34, 1699–1706. WEDMORE, C. V. and WILLIAMS, T. J. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (Lond.), 289, 646–650. WEICHMAN, B. M., MUCCITELLI, R. M., TUCKER, S. S. and WASSERMAN, M. A. (1983). Effect of calcium antagonists on leukotriene D4-induced contractions of the guinea-pig trachea and lung parenchyma. J. Pharmac. exp. Ther. 225, 310–315. WEICHMAN, B. M., WASSERMAN, M. A., HOLDEN, D. A., OSBORN, R. R., WOODWARD, D. F., KU, T. W. and GLEASON, J. G. (1983). Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analog. J. Pharmac. exp. Ther. 227, 700705. WEICHMAN, B. M., MUCCITELLI, R. M., OSBORN, R. R., HOLDEN, D. A., GLEASON, J. G. and WASSERMAN, M. A. (1982). In-vitro and in-vivo mechanisms of leukotriene mediated bronchoconstriction in the guinea pig. J. Pharmac. exp. Ther. 222, 202–208. WEICHMAN, B. M., WASSERMAN, M. A. and GLEASON, J. G. (1984). SRF 88046: A unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandin Fla and D2 in vitro. J. Pharmac. exp. Ther. 228, 128–132. WEISS, J. W., DRAZEN, J. M., COLES, N., McFADDEN, E. R., WELLER, P. F., COREY, E. J. LEWIS, R. A. and AUSTEN, K. F. (1982). Bronchoconstrictor effects of leukotriene C in humans. Science, 216, 196–198. WELTON, A. F., HOPE, W. C., TOBIAS, L. D., and HAMILTON, J. C. (1981). Inhibition of antigen-induced histamine release and thromboxane synthetase by FPL55712, a specific SRS-A antagonist. Biochem Pharmacol. 30, 1378–82. WELTON, A. F., CROWLEY, H. J., MILLER, D. A. and YAREMKO, B. (1981). Biological activities of a chemically synthetized form of leukotriene E4. Prostaglandins, 21, 287–295. WITTENBURG, H. R., WOLBLING, R. H., AEHRINGHAUS, U., PATRONO, C., PESKAR, B. M. and PESKAR, B. A. (1982). Release of slow-reacting substance of anaphylaxis from guinea pig heart and vascular tissue. In ' Leukotrienes and other lipoxygenase products. ed. P. J. Piper John Wiley and Sons, Ltd., Chichester . pp. 121–127. WOLFE, L. S. (1982). Eicosanoids: Prostaglandins, thromboxanes, leukotrienes and other derivatives of carbon-20 unsaturated fatty acids. Neurochem. 38, 114. WOODMAN, O. L. and DUSTING, G. J. (1983). Coronary vasoconstriction induced by leukotrienes in the anesthetized dog. Eur. J. Pharmac. 86, 125–128. WOODWARD, D. F., WEICHMAN, B. M. and WASSERMAN, M. A. (1982). Effect of synthetic leukotrienes on tracheal vascular permeability. Fed. Proc., (abstr.), 41, 1048. WOODWARD, D. F., WEICHMAN, B. M., GILL, C. A. and WASSERMAN, M. A. (1983). The effect of synthetic leukotrienes on tracheal microvascular permeability. Prostaglandins, 25, 131–142. YOKOCHI, K., OLLEY, P. M. SIDERIS, E., HAMILTON, F., HUHTANEN, D. and COCEANI, F. (1982). Leukotriene D4: A potent vasconstrictor of the pulmonary and systemic circulation in the newborn lamb. Adv. Prostaglandin Thromboxane Leukotriene Res. 9, 211214. YOSHIDA, S., INOH, S. ASANO, T., SANO, K., KUBOTA, M., SHIMAZAKI, H. and UETA, N. (1980). Brain free fatty acids (FFA's) and their peroxidation in ischemic and post ischemic brain injury. Stroke, 11, 128. YUSKO, P., HALL, R. A. and FORD-HUTCHINSON, A. W. (1983). Contraction of guinea pig gall bladder strips by leukotrienes and other agonists. Prostaglandins, 25, 397403. ZAVECZ, J. H. and LEVI, R. (1977). Separation of primary and secondary cardiovascular events in systemic anaphylaxis. Circ. Res. 40, 15–19. ZIJLSTRA, F. J., ADOLFS, M. J. P., VINCENT, J. E. and BONTA, I. L. (1983). The release of thromboxane A2 from the guinea pig lung parenchymal strips by leukotrienes and bradykinin as determined by bioassay and radio-immunoassay of thromboxane B2. Comparison with human lung strips. Adv. Prostaglandin Thromboxane Leukotriene Res. 10, 342–346. ZIJLSTRA, F. J., BONTA, I. L. and VINCENT, J. E. (1983). Tachyphylaxis of leukotriene C4 induced release of thromboxane A2 from guinea pig lung parenchyma and isoproterenol inhibition of this release. Adv. Prostaglandin Thromboxane Leukotriene Res. 12, 167–171. ZUKOWSKA-GROJEC, Z., BAYORH, M. A., FEUERSTEIN, G. KOPIN, I. J. (1983). Hemodynamic effects of leukotriene D4 (LTD4) in pithed spontaneously hypertensive (SHR) rats. Circulation (Abstr.), 68, III322. ZUKOWSKA-GROJEC, Z., BAYORH, M. A., KOPIN, I. J. and FEUERSTEIN, G. (1982). Leukotriene D4: cardiovascular and sympathetic effects in spontanously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. J. Pharmac. exp. Ther. 223, 183–187. ZUKOWSKA-GROJEC, Z., BAYORH, M. A., YAAR, I., KOPIN, I. J. and FEUERSTEIN, G. (1983). Leukotriene D4: Divergent cardiovascular and sympathetic effects of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Adv. Prostaglandin Thromboxane Leukotriene Res. 11, 407–412. ZUKOWSKA-GROJEC, Z., BAYORH, M. A., FADEN, A. I., KOPIN, I. J. and FEUERSTEIN, G. (1982). Pharmacological interventions in the cardiovascular effects of leukotriene D4 in pithed spontaneous hypertensive rats. In ' Leukotrienes and other lipoxygenase products. ed. P. J. Piper John Wiley and Sons, Ltd., Chichester . pp 113–120. Citing Literature Volume5, Issue2June 1985Pages 149-168 ReferencesRelatedInformation